ZEISS Launches DORC EVA NEXUS for Enhanced Cataract Surgery Experience

ZEISS Unveils the DORC EVA NEXUS for Cataract Surgery

Carl Zeiss Meditec AG, a leader in the medical technology sector, has officially launched the DORC EVA NEXUS, an innovative ophthalmic surgical system specifically designed for cataract procedures. This next-generation platform will make its anticipated debut at the European Society of Cataract and Refractive Surgeons (ESCRS) congress in London, set to take place in September 2026.

The DORC EVA NEXUS represents a significant evolution in surgical technology, expanding upon the previously established DORC EVA platform. This new system is engineered to meet the specialized needs of cataract surgeons, offering an array of advanced features that enhance performance and streamline operational workflows. Designed for stability and control, the DORC EVA NEXUS is expected to transform surgical practices by improving efficiency and consistency in the operating room.

Tailored Features for Enhanced Performance

One of the standout features of the DORC EVA NEXUS system is its cataract grade selection capability. Surgeons will benefit from programmable presets that allow for optimized phacoemulsification, aspiration, and irrigation settings tailored to a patient’s specific cataract grade. This level of customization facilitates seamless adjustments during surgery, all controlled via an intuitive footswitch or touchscreen interface.

As Dr. Dominik Beck, head of the Posterior Surgery Business Sector at ZEISS Medical Technology, notes, “With the DORC EVA NEXUS cataract solution, ZEISS redefines surgical capabilities, delivering innovation that supports precision in surgical decision-making and outcomes.”

Dr. Marcus Drodofsky, a cataract surgeon at Augenärzte Osnabrück in Germany, shares his initial experiences with the DORC EVA NEXUS: “Having used the predecessor for over a decade, the improvements seen with the DORC EVA NEXUS make a difference in daily surgical practice. It allows my staff and I to feel more in control, ultimately leading to better patient experiences and surgery outcomes.”

Cutting-Edge Technology Integrated into the System

The DORC EVA NEXUS incorporates several cutting-edge technologies that work together to enhance the surgical experience. At the center of this system is the VacuFlow VTi pump, an advanced fluidics innovation that offers precise, pulsation-free flow during procedures. This not only enhances operational efficiency but also provides greater control over cataract surgery processes.

Moreover, the SMART IOP™ feature is unique to the DORC EVA NEXUS. This technology autonomously compensates for pressure fluctuations, ensuring a stable intraocular pressure that is vital during cataract operations. Reports have indicated that this feature results in substantially lower anterior chamber pressure and improved responsiveness, enhancing surgical success.

The lightweight DORC EVA SURE TOUCH phaco handpiece, alongside a full suite of high-performance phaco tips, allows for superior chamber stability and ultrasound efficiency. Coupled with a customizable and wireless dual linear footswitch, surgeons can fine-tune their control over aspiration and ultrasound settings, which is critical for successful cataract extraction procedures.

Future Outlook and Global Availability

Starting with its launch in select European markets, the DORC EVA NEXUS is expected to receive global availability pending regional regulatory approvals. ZEISS aims to broaden access to this state-of-the-art surgical system, empowering cataract surgeons worldwide with improved tools for patient care.

For more information about the DORC EVA NEXUS and to see the system in action, attendees are encouraged to visit the ZEISS booth located in the South Event Hall at the ESCRS congress in London or explore online at www.zeiss.com/med.

As the demand for enhanced cataract surgical solutions continues to grow, the introduction of the DORC EVA NEXUS underscores ZEISS' commitment to innovation and excellence in medical technology, promising to uplift the standard of patient care for years to come.